Home / Learn

Learn

ACCC education and advocacy support offers our multidisciplinary membership a variety of diverse and enriching resources that address the complex changes and challenges in delivering quality cancer care.

Our ever-growing ACCC community of nearly 30,000 practitioners and healthcare professionals have access to member-driven education programs delivered in a wide range of formats. These formats include live national and regional meetings, webinars, workshops, publications, white papers, case studies, surveys, environmental scans, and literature reviews, as well as onsite learning opportunities, peer-to-peer learning, focus groups, and more.

ACCC members are invited to get involved. Contact us at resources@accc-cancer.org to learn more.

ACCC offers education and resources to help multidisciplinary cancer care teams stay informed of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.

ACCC is dedicated to helping the oncology community advance new therapies, expand access to clinical trials, and to close the gap in cancer care delivery by offering the latest education and resources on real-world research, evidence, and clinical trials.

Cancer care services that address the full spectrum of a patient’s needs—physical, nutritional, emotional, psychosocial, spiritual, and financial—have been found to greatly improve survivor’s quality of life and outcomes.

Through the Financial Advocacy Network tools and resources, ACCC's goal is to empower providers to proactively integrate financial health into the oncology care continuum and help patients gain access to high-quality care for a better quality of life.

By supporting our members and the entire oncology specialty, we can prioritize equity, diversity, and inclusion in quality cancer care delivery, as well as within the oncology workforce.

ACCC is leading the way in transforming oncology practice management and operations resources that connect real-world challenges with real-world solutions.

Helping to bring personalized cancer care into focus, ACCC transforms complex science into clear and actionable education that brings clarity to patient care decisions.

ACCC offers a variety of webinars, continuing education opportunities, abstracts, presentations, the Oncology Issues journal, and more publications.

Webinars & E-Learning

The ACCCeLearning platform provides multidisciplinary education and resources that support the different needs of our members. With a variety of flexible online learning options that fit individual learning preferences, you have your choice of in-depth courses or shorter learning formats to gain quick knowledge.

Explore by Topic

ACCCeLearning offers live and on-demand webinars, webcasts, and continuing education courses under the following topics:

Latest On-Demand Webinars

Impact of Nurse Navigation in Transitions of Lung Cancer Care
Optimizing Treatment with Molecular Tumor Boards

Learn from experts Derek B. Allison, MD, and Justine C. Pickarski, MS, LGC, about how they developed Markey Cancer Center’s statewide molecular tumor board as well as lessons learned and key takeaways.
Cultivating Care: Growing Sustainable Financial Advocacy Programs to Better Serve Patients

For people living with cancer, the financial challenges of treatment can create significant burdens across the continuum of care. In this webinar, Dr. Margaret Liang will explore some of the drivers and sources of financial toxicity for patients and shed light on the Association of Cancer Care Centers Financial Advocacy Services Guidelines, an evidence-based framework developed by experts and patient advocates to prevent, detect, and mitigate financial hardship during cancer care. Learn how the guidelines, which include an assessment tool that identifies program gaps and opportunities, offer cancer care centers a customizable pathway to expand their capacity to equitably serve patients with cancer.

View Complete Library of Virtual Education

Continuing Education Activities

ACCC’s mission is to promote the education and training of the multidisciplinary oncology care team, with the goal of improving the treatment and management of patients with cancer. Our portfolio includes education for all learners, regardless of the stage they are in their career.

Advances in Cancer Immunotherapy Series: A Focus on Toxicity Management

Tuesday, May 14 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of toxicity management. FREE for healthcare professionals, students, patients and patient advocates.

Physician Education: 3.75 AMA PRA Category 1™
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Genitourinary Cancers

Tuesday, June 11 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers. FREE for healthcare professionals, students, patients and patient advocates.

Physician Education: 3.75 AMA PRA Category 1TM
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Lung Cancer

Tuesday, June 25 from 1-5 PM EST

Join SITC and a panel of experts, via Zoom for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for lung cancer. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Hematologic Malignancies

Wednesday, September 11 from 1-5 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for hematologic malignancies. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Intratumoral Therapies Vaccines and Cytokines

Wednesday, October 9 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines. FREE for healthcare professionals, students, patients and patient advocates.
Register Now

Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in Metastatic Colorectal Cancer (mCRC)

In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps. At the end of this workshop, participants will be able to develop a personalized action plan for incorporating new insights and competencies into practice, learn to develop practical biomarker testing protocols for metastatic colorectal cancer, and how this information can support personalized treatment decisions for improved patient outcomes.

Credits Available: This activity is awarded 4.5 hours of AMA PRA Category 1 Credit(s)™ and nursing contact hours. For additional CE information, please visit tffevents.com/crc.

More Information

Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer

Included in this course are data from the PEACE-1 phase 3 trial exploring triple therapy, ongoing trials in metastatic castration-sensitive prostate cancer, and quality of life studies on systemic therapies.

This activity provides guidance on the optimal management of mCSPC to oncologists, urologists, oncology advanced practitioners and other members of the multidisciplinary cancer care team. The program addresses some of the challenges in optimal sequencing of care in mCSPC and provides an opportunity to discuss with leading oncology experts and colleagues how new research clinical updates can be translated into new patient care strategies.

Speakers:

Archana Ajmera, MSN, ANP-BC-AOCNP, Advanced Practice Provider Supervisor, Division of Hematology/Oncology, UCSD Moores Cancer Center
Pedro C. Barata, MD, MSC, Assistant Professor, Deming Department of Medicine Division of Hematology/Oncology, Genitourinary Cancers Tulane University, Tulane University
Erik Castle, MD, FACS, Professor of Urology, Tulane University
Lisa M. Holle, PHARMD, BCOP, FHOPA, FISOPP, Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, UConn School of Medicine

View Course

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management

This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

Session 1:  Learn what factors influence testing selection for patients with advanced NSCLC.
Session 2:  Gain clarity on biomarker testing methodology and recommendations.
Session 3:  Hear insights on advanced NSCLC treatment opportunities and optimizing patient care.

Credits Available: This activity offers up to 4.5 hours of CME/CMLE credit.
Enroll Today

Presentations and Abstracts

ACCC presents oral and poster presentations that represent the spectrum of cancer care at international conferences throughout the year.

[Abstract] Perceived Barriers to Optimal Care in Head and Neck Cancer: A Mixed-Methods Study Nov 14, 2024

Presented at Journal of the Advanced Practitioner in Oncology (JADPRO) Live 2024 in Grapevine, Texas.
Improving Care Coordination to Address Healthcare Inequities in Lung Cancer Nov 11, 2024
Presented at the IASCL 2024 World Conference on Lung Cancer.
[Abstract 6079 and Poster 394] Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study Jun 18, 2024

This is a visual representation of an online publication from the American Society of Clinical Oncology 2024 Annual Meeting, May 31 – June 4, 2024.

View All Presentations and Resources by Topic

Publications

ACCC members consistently give ACCC publications high marks for their timeliness and usefulness. Experts in the field of oncology contribute to ACCC's publications and provide a solution-based approach to educating oncology healthcare professionals about streamlining and improving cancer services, practice management trends and strategies; implementing new treatments and technology; and planning for regulatory and legislative change.

Oncology Issues

Oncology Issues is the official journal of the Association of Community Cancer Centers (ACCC). As one of the only non-clinical, programmatic journals covering cancer, Oncology Issues provides “how-to” articles for the entire multidisciplinary oncology care team, on a wide range of topics.

Ambulatory Care Excellence (ACE): A Proven Framework for Streamlined Cancer Care Delivery

By Tara DelGrippo, Disha Sawhney, Colleen Eroh, Sarah Porzig, Jordyn Lynn Biro, and Anna Liza Rodriguez

Oncology care is shifting from inpatient to outpatient settings, with ambulatory care becoming increasingly complex and requiring efficient processes, clear communication, and seamless care coordination. In response, 2025 ACCC Innovator Award Winner Fox Chase Cancer Center developed the Ambulatory Care Excellence Model to standardize roles, embed care-coordination time, and streamline communication.

Read Full Article

Also In This Issue:

Scaling Early Detection Across Rural America: Lifepoint Health’s Healthy Person Program
2025 ACCC Innovator Award Winner Lifepoint Health recognized that patients in rural and underserved areas face barriers to early detection of cancer and high-risk conditions. In response, they developed the Healthy Person Program, which combines computational linguistics, standardized workflows, and nurse navigation to identify patients at risk, coordinate follow-up, and measure outcomes across the entire health system.
Implementing a Structured, Scalable Geriatric Oncology Program
Older adults with cancer face unique vulnerabilities—such as comorbidities, frailty, and polypharmacy—that affect treatment tolerance and outcomes, requiring an age-inclusive approach to care. Recognizing this, 2025 ACCC Innovator Award Winner Penn Medicine Princeton Health developed a structured, scalable geriatric oncology program and integrated the Practical Geriatric Assessment into its workflows.
Precision With Purpose: Transforming Oncology Care Through Predictive Insights
Research continues to demonstrate that early palliative care involvement improves the patient and caregiver experience, enhances quality of life, and reduces emergency department visits and hospitalizations. WellSpan Cancer Institute, a 2025 ACCC Innovator Award Winner, broke down barriers to palliative care referrals by engaging the health system’s End-of-Life Care Index within the electronic health record.
Staying Connected Between Visits: A Sustainable Model for Remote Monitoring
For many patients with cancer, the most difficult moments occur alone at home, when symptoms arise and they feel unsure whether to contact their care team. To address these issues early and prevent a quiet concern from turning into a crisis, 2025 ACCC Innovator Award Winner Highlands Oncology leveraged AI to implement an electronic patient-reported outcomes program across multiple sites.
Bringing Cancer Care Home: The Shaw at Home Model for Community-Based Oncology Palliative Care
After realizing that a growing number of patients with cancer experienced significant delays—and in some cases, denials—in home care and hospice services, Shaw Cancer Center built an oncology-specific home- and community-based palliative care program from the ground up, winning them a 2025 ACCC Innovator Award.
Embedding Precision Medicine Into Gynecologic Cancer Care: Lessons From a Nationwide Quality Improvement Effort
To evaluate and strengthen biomarker testing workflows in gynecologic oncology, ACCC launched a quality improvement initiative with 3 geographically diverse cancer centers, representing both academic and community settings. Over the course of 6 months, this initiative yielded an assessment of feasibility, identified common barriers, and generated actionable strategies for improvement of biomarker use.